sequenced with primer M13F-21 (SI Table 5 ). NGS used the Illumina platform. The protocol for 27 direct sequencing of swab DNA without target enrichment has been described separately (7). 28
For selected swab DNA specimens, HSV-2 DNA was enriched using a custom biotinylated 29 120bp oligonucleotide panel (IDT, Coralville, IA) tiling across HSV-2 strain HG52 Genbank 30 NC_001798 genome (Greninger et al. in preparation) . For these samples, libraries were 31 created using Fragmentase TM (New England Biolabs, Ipswich, MA), E. coli DNA polymerase, T4 32 polynucleotide kinase, and Taq DNA polymerase (8), followed by amplification with barcoded 33
TruSeq TM (Illumina, San Diego, CA) primers and pooling prior to enrichment. Libraries were 34 enriched using the manufacturer's reagents and protocols (IDT) and sequenced using a single 35 ended v3 150bp kit and MiSeq instrument (Illumina). Non-enriched sequence reads were filtered 36 by discarding human reads and aligning to the HSV-2 HG52 genome while post-enrichment 37 libraries were aligned directly the HG52 genome. 38
39
HSV genotyping by digital droplet PCR (ddPCR). Two reactions were used for UL39 and one for 40 UL30. The first UL39 reaction resolved HSV type in the 5' portion of the long UL39 41 recombination (see main text). Primers and probes (SI Table 4 ) allowed differentiation of HSV 42 type in the vicinity of HSV-2 UL39 bp 2415-2428 (coordinates from Genbank M12700.1 for 43 strain HSV-2 186) from the homologous but different HSV-1 sequence in the vicinity of UL39 bp 44 2394-2407 (Genbank JN555585.1 for strain HSV-1 17+). The second UL39 reaction resolved 45 HSV type towards the 3' end of the long UL39 recombination. Primers and probes specified 46 type-specific signals in the vicinity of HSV-2 UL39 bp 2671-2683, homologous to but different 47 from HSV-1 sequence in the vicinity of UL39 bp 2650-2662 region. The UL30 reaction 48 differentiated between bp 3000-3100 of the HSV-2 strain 186 sequence from almost identical 49 regions of HSV-2v. For each reaction, 25 µl mixes were assembled from 12.5 µl ddPCR SI 50 2xSupermix (BioRad), 500 nM each primer, 250 nM each probe and 10 µl DNA. Twenty µl was 51 used to generate droplets that were amplified, analyzed and counted. Deletion is ambiguous as strain 186 sequence is SGPS in this region. Change could also be recorded as deletion SGP. In strain SD90e, one S is retained.
2 Deletion is ambiguous as strain 186 sequence is GSG in this region. Deletion could also be recorded as deletion GS. In strain HG52, one G is retained.
3 Insertion is ambiguous as strain 186 sequence is GAG in this region. In strain D39650, GAG peptide expands to GAGAG.
Supporting Information 2   2  2  2  2  2  2 1 Loci numbers in consensus sequence from aligning the indicated UL39 sequences with Clustal Omega (Megalign, Lasergene, Inc).
2 Except for scattered strain-specific SNPs and indels, all loci in the 5' and 3' regions outside of the region detailed in this table, for all HSV-2 strains, have HSV-2 strain SD90e/186-like sequences.
3 HSV-2 alleles are capitalized and HSV-1 alleles are lower case. 4 The HIV infection status of the subjects from whom these samples were obtained is G19080 1 UL39 coordinates from HSV-2 strain 186 (Genbank JN561323.2), or HSV-1 strain 17+ (Genbank JN555585.1). UL30 coordinates from HSV-2 strain HG52 or chimpanzee alphaherpesvirus (Genbank JQ360576.1).
2 Name of primer followed by 5'  3' sequence. Note that underlined S indicates an equimolar mixture of G and C; underlined R is equimolar mix of A and G.
3 Name of probe followed by 5'  3' sequence. VIC = proprietary dye, MGB = minor groove binder quencher dihydrocyclopyrroloindole tripeptide, FAM = 6-carboxyfluorescein. Underlined nucleotides are discriminatory between HSV-1 and HSV-2 or between HSV-1 and ChHV.
